---
audienceLevel: patient
cancerTypes:
- bladder
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Erdafitinib - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/erdafitinib
version: v1
---

# Erdafitinib - NCI

# Erdafitinib

Placeholder slot

(ER-duh-FIH-tih-nib)

Erdafitinib works by blocking a protein in some cancer cells that signals the cancer cells to multiply. This may keep cancer cells from growing and may kill them. Erdafitinib is a type of targeted therapy drug called an enzyme inhibitor.

US Brand Name(s)

Balversa

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee&audience=consumer)

## Use in Cancer

Erdafitinib
is approved to treat:

- **[Urothelial carcinoma](/Common/PopUps/popDefinition.aspx?id=783188&version=Patient&language=English)** (a type of [bladder cancer](/Common/PopUps/popDefinition.aspx?id=444968&version=Patient&language=English)) that has spread and has an abnormal *[FGFR3](/Common/PopUps/popDefinition.aspx?id=798336&version=Patient&language=English)* gene. It is used in adults whose cancer got worse during or after treatment with at least one type of [systemic therapy](/Common/PopUps/popDefinition.aspx?id=45922&version=Patient&language=English).

Erdafitinib
is also being studied in the treatment of other types of
cancer.

## More About Erdafitinib

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/741845) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Erdafitinib](https://medlineplus.gov/druginfo/meds/a619031.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Erdafitinib](https://www.cancer.gov/research/participate/clinical-trials/intervention/C103273) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
